COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
申请人:RIGEL PHARMACEUTICALS, INC.
公开号:US20130090310A1
公开(公告)日:2013-04-11
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.
Compositions and methods for inhibition of the JAK pathway
申请人:Rigel Pharmaceuticals, Inc.
公开号:US11174251B2
公开(公告)日:2021-11-16
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.
本发明公开了式 I 的化合物、含有这些化合物的组合物,以及这些化合物和组合物用于治疗调节 JAK 通路或抑制 JAK 激酶(尤其是 JAK 2 和 JAK3)具有治疗作用的疾病的方法。还公开了制造这些化合物的方法。
US9920041B2
申请人:——
公开号:US9920041B2
公开(公告)日:2018-03-20
Stereochemical considerations and the antiinflammatory activity of 6-amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ols and related derivatives
作者:Shing Chun Wong、Sandra Sasso、Howard Jones、James J. Kaminski
DOI:10.1021/jm00367a005
日期:1984.1
significant antiinflammatoryactivity. The antiinflammatoryactivity of the amino alcohols was also significantly influenced by the position and nature of the aromatic substituent. Latentiation of the amino alcohol function resulted in analogues exhibiting antiinflammatoryactivity equivalent to their amino alcohol precursors. Masking the amino alcohol function as a more stable derivative led to analogues